Metraipolis › archive › dc_d4e9aeff5164
Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies — Europe PMC PMID:41465349
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41465349
- DOI
- 10.3390/ijms262411918
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T18:25:56.306Z
- SHA-256 of the archived text
46bff75288e512122f3fe073d3740642d1b8be591e4be4c8ff11ebf06bcf1f11- Stable URL of this page
https://metraipolis.com/documento/dc_d4e9aeff5164
How to cite
Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies — Europe PMC PMID:41465349 — Europe PMC (en), https://europepmc.org/article/MED/41465349 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d4e9aeff5164 (Metraipolis archive dc_d4e9aeff5164, sha256 46bff75288e512122f3fe073d3740642d1b8be591e4be4c8ff11ebf06bcf1f11)
BibTeX
@misc{dcd4e9aeff5164,
title = {Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies — Europe PMC PMID:41465349},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41465349},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d4e9aeff5164; sha256 46bff75288e512122f3fe073d3740642d1b8be591e4be4c8ff11ebf06bcf1f11},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465349. Agents can read the archived copy with the MCP tool read_document.